Welcome to our dedicated page for BWX Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
BWX Technologies, Inc. filed an amendment to its Q2 2026 quarterly report solely to add omitted iXBRL data; financial results remain unchanged. For the quarter ended June 30, 2026, revenue was $901,625 (in thousands), up 18.0% year over year, and net income attributable to the company was $89,014 (in thousands), or $0.97 per diluted share.
For the first six months, revenue reached $1,761,842 (in thousands) and net income was $180,084 (in thousands), driven by strong growth in Commercial Operations, where revenue rose to $586,158 (in thousands) and operating income to $48,361 (in thousands). Government Operations revenue increased to $1,179,191 (in thousands) while operating income edged slightly lower to $204,819 (in thousands) after prior-year contract catch-up benefits.
Operating cash flow was $249,003 (in thousands) for the first half, and cash and restricted cash totaled $616,273 (in thousands) with no borrowings under a $1.25 billion revolving credit facility. Backlog stood at $8,398.1 million, about 55% expected to be recognized as revenue by the end of 2027. Recent moves include the acquisitions of Aerojet Ordnance Tennessee and Kinectrics, the July 2026 purchase of Precision Components Group, and an agreement to sell the medical business to Nordic Capital for up to $800 million while retaining a minority interest.
BWX Technologies, Inc. reported higher results for the quarter and six months ended June 30, 2026. Second‑quarter revenue was $901.6 million, up from $764.0 million, and net income attributable to BWXT was $89.0 million, compared with $78.4 million. Diluted EPS was $0.97 versus $0.85.
For the first half of 2026, revenue rose to $1.76 billion and net income attributable to BWXT to $180.1 million. Commercial Operations grew sharply, with revenue of $586.2 million and operating income of $48.4 million, helped by the 2025 Kinectrics acquisition, while Government Operations revenue increased modestly and operating income was slightly lower.
Cash from operating activities increased to $249.0 million in the first half, and cash and restricted cash totaled $616.3 million at June 30, 2026 against $2.02 billion of long‑term debt. Backlog reached $8.40 billion, with about 55% expected to be recognized as revenue by the end of 2027. BWXT completed the acquisition of Precision Components Group on July 1, 2026 and agreed to sell its medical business to Nordic Capital in a transaction valued at up to $800 million, retaining a minority interest and providing ongoing isotope and radiochemical support.
BWX Technologies reported strong second quarter 2026 results, with revenue of $901.6 million, up 18% year over year, and GAAP net income of $89.1 million, up 14%. GAAP diluted EPS rose to $0.97, non-GAAP EPS to $1.07, and consolidated adjusted EBITDA reached $155.5 million, a 7% increase. Commercial Operations revenue grew 72% to $302.5 million, while Government Operations revenue increased 2% to $601.3 million. Free cash flow was $115.0 million versus $126.3 million a year earlier, reflecting higher capital expenditures.
The company announced the sale of its medical business to sharpen focus on nuclear national defense and commercial nuclear power, and closed the acquisition of Precision Components Group on July 1, 2026, adding a U.S. commercial nuclear manufacturing footprint. Total backlog increased to 8,398,081 (in thousands) from 6,015,191 (in thousands) a year earlier. Reflecting a strong first half and the PCG contribution, BWXT raised 2026 guidance to revenue of approximately $3,800 million, adjusted EBITDA of $662–$672 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million. The board declared a quarterly dividend of $0.27 per share payable September 4, 2026.
BWX Technologies, Inc. Chief HR Officer Gonzalo Raul Cajade reported routine equity compensation activity involving company stock. He exercised derivative securities to acquire 332 shares of common stock, reflected as a conversion of restricted stock units. In a related move, 124 shares of common stock were disposed of to satisfy tax obligations through a tax-withholding disposition at $194.65 per share, rather than through an open-market sale.
After these transactions, he directly holds 378 shares of BWX Technologies common stock. Footnotes state that restricted stock units vest in three equal annual installments beginning July 1, 2026, indicating an ongoing multi-year vesting schedule for his equity awards.
Joseph Kirwan Miller, President, Government Operations at BWX Technologies, exercised 237 Restricted Stock Units into the same number of shares of Common Stock on July 1, 2026. To cover tax obligations, 106 of these shares were withheld at $194.65 per share. After these transactions, he directly holds 5,242 shares of Common Stock. The company also notes that related RSUs vest in three equal annual installments beginning July 1, 2026.
BWX Technologies director Jan Bertsch reported an acquisition of 35.47 Dividend Equivalent Rights (DERs) tied to existing restricted stock units. These DERs were granted at an exercise price of $0.00 and increase her directly held DER balance to 2,242.48 units.
According to the disclosure, the DERs accrue on nine restricted stock unit grants for which she has elected to defer receipt of the underlying shares. Each RSU and each DER represents a contingent right to receive one share of BWX common stock, and the DERs will be delivered proportionately with the related deferred RSUs.
Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Gerhard F. Burbach received a routine compensation-related grant of 19.620 Dividend Equivalent Rights tied to existing restricted stock units. Following this award, he holds 777.920 such rights, each representing a contingent right to receive one share of BWXT common stock, delivered in line with his RSU deferral election.
JASKA JAMES M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director James M. Jaska received a grant of dividend equivalent rights tied to existing deferred restricted stock units. On the transaction date, he was awarded 23.95 dividend equivalent rights at a price of $0.00 per right, increasing his total to 1,110.39 such rights. Each dividend equivalent right and related restricted stock unit represents a contingent right to receive one share of BWX common stock, delivered in proportion to the underlying RSUs according to his deferral election. This filing reflects routine equity-based compensation rather than an open-market stock purchase or sale.
JABLONSKY DANIEL L reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Daniel L. Jablonsky reported an automatic compensation-related award of 1.29 Dividend Equivalent Rights (DERs) tied to previously granted restricted stock units. Following this grant, he holds 1.45 DERs. Each RSU and DER represents a contingent right to receive one share of BWXT common stock, to be delivered in line with his prior deferral election.
Krieg Kenneth J reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Kenneth J. Krieg received a grant of 30.59 Dividend Equivalent Rights on June 5, 2026. These rights accrued on nine restricted stock unit (RSU) grants for which he previously elected to defer receipt of the underlying shares.
Each RSU and each Dividend Equivalent Right represents a contingent right to receive one share of BWX Technologies common stock. Following this grant, Krieg holds a total of 1,450.81 Dividend Equivalent Rights, which will be delivered proportionately over time in line with the deferred RSUs.